Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-4,200
Closed -$52K 8843
2015
Q4
$52K Buy
4,200
+4,100
+4,100% +$56.1K ﹤0.01% 7287
2015
Q3
$1K Sell
100
-300
-75% -$4.28K ﹤0.01% 8807
2015
Q2
$5K Buy
+400
New +$4.99K ﹤0.01% 8552
2015
Q1
Sell
-2,000
Closed -$23K 9085
2014
Q4
$23K Sell
2,000
-100
-5% -$981 ﹤0.01% 7716
2014
Q3
$19K Sell
2,100
-500
-19% -$5.02K ﹤0.01% 7500
2014
Q2
$30K Buy
2,600
+700
+37% +$8.55K ﹤0.01% 7087
2014
Q1
$24K Sell
1,900
-900
-32% -$11.5K ﹤0.01% 7218
2013
Q4
$37K Sell
2,800
-200
-7% -$2.78K ﹤0.01% 6197
2013
Q3
$47K Buy
3,000
+200
+7% +$3.08K ﹤0.01% 5829
2013
Q2
$52K Buy
+2,800
New +$46.2K ﹤0.01% 5649

Other funds holding XXIA

Citadel Advisors's XXIA Position: Q2 2017 in Review

Citadel Advisors sold out of Ixia (XXIA) in Q2 2017, closing a stake of 42,730 shares — an estimated $840K sold.

Citadel Advisors first reported a position in XXIA in Q2 2013 and held it in 16 quarters. The position peaked at $18.1M in Q4 2013. 1 fund tracked by Wall St. Rank holds XXIA as of Q2 2017.

  • Citadel Advisors reported no remaining Ixia position as of Q2 2017 after selling out during the quarter.
  • Citadel Advisors sold 42,730 Ixia shares in Q2 2017, an estimated $840K.
  • Citadel Advisors first reported a position in Ixia in Q2 2013 and held it in 16 quarters.
  • Citadel Advisors's Ixia position peaked at $18.1M in Q4 2013.
  • 1 fund tracked by Wall St. Rank held Ixia as of Q2 2017.

Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.